Diacomit — Medical Mutual
Dravet Syndrome
Initial criteria
- Patient is age ≥ 6 months and weighs ≥ 7 kg; AND
- Patient meets ONE of the following: (a) Patient is taking concomitant clobazam; OR (b) Patient is unable to take clobazam due to adverse events as determined by the prescriber; AND
- The medication is prescribed by or in consultation with a neurologist
Reauthorization criteria
- Patient is currently receiving Diacomit and is responding to therapy (e.g., reduced seizure severity, frequency, and/or duration) as determined by the prescriber
Approval duration
1 year